PSI CRO and Appian Launch AI-Driven Clinical Trial Site Selection Platform
- PSI CRO has partnered with Appian to create an AI-powered platform for automating clinical trial site selection.
- The solution aims to enhance site selection accuracy and reduce patient recruitment delays by integrating AI with existing systems.
Operational Impact
This collaboration allows PSI CRO to improve site selection processes, potentially increasing trial enrollment rates across various therapeutic areas and geographies.
Source: PharmaSource RSS
Viedoc and Bioforum Enhance Clinical Data Integration with New Partnership
- Viedoc and Bioforum formalize a partnership to integrate Viedoc EDC with BioGRID, enhancing clinical data review processes.
- The collaboration aims to provide study teams with a comprehensive view of clinical data, improving decision-making and analytics.
Operational Impact
This integration allows Bioforum's BioGRID platform to utilize data from Viedoc EDC, improving the workflow for clinical data review and analytics.
Source: PR Newswire pharma category RSS
ProtaGene Appoints Matthias Bucerius as CEO to Enhance Analytical Services for Biologics
- ProtaGene has appointed Matthias Bucerius, PhD, as CEO to strengthen its regulatory-ready analytical services for biologics and advanced therapies.
- Bucerius brings extensive experience from Merck KGaA, where he oversaw drug substance manufacturing sites and FDA inspections.
Operational Impact
Bucerius's leadership is expected to improve data quality and project delivery across ProtaGene's four sites in Europe and North America.
Source: PharmaSource RSS
References
- PharmaSource RSS — PSI CRO and Appian Launch AI-Driven Clinical Trial Site Selection Platform
- PR Newswire pharma category RSS — Viedoc and Bioforum Enhance Clinical Data Integration with New Partnership
- PharmaSource RSS — ProtaGene Appoints Matthias Bucerius as CEO to Enhance Analytical Services for Biologics